Icon price target lowered to $255 from $270 at BofA
BofA analyst Michael Ryskin lowered the firm’s price target on Icon (ICLR) to $255 from $270 and keeps a Buy rating on the shares. The firm ...
TD Cowen cuts ICON stock price target to $254, maintains Buy rating
TD Cowen adjusted its financial outlook for ICON plc (NASDAQ:ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology, and medical device industries.
Investing23d
ICON stock target cut, maintains buy rating on financial guidance
On Wednesday, Jefferies analyst David Windley adjusted the price target for ... led to market reactions as it fell short of expectations. Analyst also highlighted that ICON's margins are under ...